chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had had 3 short A-fib episodes prior to receiving the 3rd dose of the vaccine. None that last more than an hour. On  New Year, 01/01/2022,  approximately a month after I had received  the vaccine,  I had the prolong  A-fib episode,  that lasted 7.5 hours. At the 7 hour mark,  I went tot ER.  They admitted me to the ER. I was in the A-fib phase for 8 hours.  They told me I needed to see a cardiologist and I was able to see a cardiologist  on 01/3/2022 or 01/04/2022. He diagnosed me with a-fibrillation with an EKG.  They told me how serious it was. I decided to go with a  pill in a pocket as a treatment.  And when you go into A-fib it stops the A-fib, it stops it. On 2/25/2022 I was admitted into the hospital and I was discharged on 2/26/2022. I had an A-fib episode and I passed out.  When I kept having events, the A-fib episodes were  going on for hours at a time. I  decided to go into surgery, because  the A-fibs kept coming. I went back to Arizona and had the surgery on  3/22/2022, the cardiac ablation  on the 03/10/2022 they  implanted the cardiac  monitor. Since the surgery and the healing process, I have not had any other issues since then.
This case was reported in a literature article and described the occurrence of anaphylaxis in an infant male subject who was vaccinated with Dtap vaccine (manufacturer unspecified), Hepatitis A vaccine, MMR vaccine (non-GSK) and IPV (non-GSK). The subject's medical history included premature birth at 30 weeks gestation. Concurrent medical conditions included cataract, lens replacement, latex allergy and Ig E positive for gelatin. On an unspecified date the subject received unspecified dose of Dtap vaccine (unknown route, unknown lot number), unspecified dose of Hepatitis A vaccine (unknown route, unknown lot number), unspecified dose of MMR vaccine (Non-GSK) (unknown route, unknown lot number), unspecified dose of IPV (Non-GSK) (unknown route, unknown lot number). 2 hours after vaccination with Dtap vaccine, Hepatitis A vaccine, MMR vaccine (Non-GSK) and IPV (Non-GSK), the subject experienced anaphylaxis, cough, sore throat, welt, shortness of breath, wheezing and urticaria. This case was assessed as medically serious by GSK. The subject was treated with Oral steroids and diphenhydramine. At the time of reporting the events were resolved. The Program was established in 1986 in response to vaccine safety concerns. A unique feature is a table of compensable injuries, the Vaccine Injury Table (VIT). Anaphylaxis is a listed adverse event with an interval of 0 to 4 hours for several vaccines. In 2009, the Program charged the Institute with the task of completing a comprehensive review of the medical literature regarding adverse events related to vaccines so that the VIT could be updated. Concurrent with the Institute's review, the author undertook a systematic analysis of the Program's anaphylaxis case experiences. The Program administrative database was queried for all cases submitted to the Program alleging anaphylaxis or anaphylactic shock for the 10-year period from January 1, 2000 through December 31, 2009. Cases were categorized as anaphylaxis, possibly allergic-not anaphylaxis, and not anaphylaxis or allergic. The anaphylaxis cases all met the agency case definition and were further subdivided into 3 levels of diagnostic certainty using major and minor criteria, with level 1 being the greatest level of certainty. Possibly allergic cases were defined as those for which there were signs and/or symptoms compatible with an allergic reaction occurring within 4 hours of injection but that did not meet any of the agency case definitions for anaphylaxis. All of our anaphylaxis cases met the agency diagnostic certainty and, with an interval of 0 to 4 hours, are consistent with the current VIT. This case was classified at level 1 of certainty. The subject had previous testing demonstrating elevated IgE levels to gelatin, a known risk factor for vaccine-associated anaphylaxis. This review represented the first systematic approach in analyzing the Program experience with anaphylaxis and will be useful when the VIT is updated. This is one of 9 cases reported in the same article and represented 8 different vaccines containing at least 11 different vaccine antigens.
dizziness, nausea, vomiting, headache for 2 days.  In bed from 9:00 a.m. to 4:00 p.m. on first day.    Too dizzy to get up from bed.  Second day was able to be up but still feeling a bit of nausea.  Took  tylenol for headache
I am not sure if the vaccine was called "FLUARIX," that may not be correct. The flu clinic said my daughter received a Glaxo Smith Kline quad prefilled syringe without preservatives, Lot # 27LY3. The day after the vaccine, she developed a rash with hives at the site of the injection, then a half hour to an hour later, she also developed facial flushing, felt hot all over, and her throat tightened (lump in throat, voice became hoarse voice higher pitched). She was treated with antihistamines, epi pen, and prednisone. First went to an urgent care clinic, then to the ER. Symptoms diminished after treatment.
Developed a rash over entire body one day after vaccine. Also hives on trunk and face.
Pt recvd 3 Hepatitis-B vax doses on 26JUL89, 29AUG89, & 25JAN90; following these titer=17; one yr later titer was neg; pt was given a 4th dose 26APR91 p/4th dose titer=128;
Patient is experiencing fever, nausea without vomitting, and malaise. Eyes are red.
This spontaneous report was received from a health professional refers to a patient of unknown age and gender. The patient's medical history and concomitant medications were not reported. On 05-JUL-2016, the patient was vaccinated with VAQTA (lot # L015460, expiry date: 20-JUL-2017) for prophylaxis (dose and route was not reported), which was stored improperly(reported as vaccine temperature excursion) (Product storage error).
Pain; Swelling; This spontaneous case was received on 31-Aug-2020 from other non-health professional via agency (reference number: SEQW20-01068) and concerned a female patient of unknown age.  The patient's medical history and concomitant medications were not reported.   On an unspecified dates, reported as in the previous years, the patient was vaccinated with INN Seasonal flu vaccines [influenza virus vaccine polyvalent; dose, route of administration, anatomical location: not reported] for flu prevention.   The batch number was not reported.  On an unspecified dates, an unknown amount of time after receiving INN Seasonal flu vaccine, the patient experienced pain and swelling.   The outcome of events was not reported.  The reporter did not provide causality assessment.  This case is linked to case 202004282 (the same patient).  Company comment:The patient developed pain and swelling on an unknown date and unknown amount of time after vaccination with the suspect product, INN Flu Vaccine Seasonal. Chronology is unclear. No information regarding concomitant medication and medical history was provided. Based on this information, causal relationship for both events is assessed as unassessable.; Sender's Comments: The patient developed pain and swelling on an unknown date and unknown amount of time after vaccination with the suspect product, INN Flu Vaccine Seasonal. Chronology is unclear. No information regarding concomitant medication and medical history was provided. Based on this information, causal relationship for both events is assessed as unassessable.
Patient admitted to ICU with AHRF due to COVID infection; bacterial bilateral pneumonia, hypernatremia; AKI on CKD3; started on antibiotics and O2 supplementation via NC: DNR/DNI; comfort care; transferred to inpatient hospice where patient died.
Symptoms: Nausea; Rapid and Skipping Heartrate. Duration: 3 Days
pt recvd vax; 8 mo later,inject site area(2" in diam) was indurated & erythematous; a sterile abscess was dx on 2may94;
Patient presented to the ED on 1/28/22 for near syncope. Patient presented to the ED on 2/2/22 for syncope. These visits are within 6 weeks of receiving covid vaccination.
sore throat; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left, administration date 27Feb2021 12:15 (Lot number: EN6202) at the age of 74 years as dose 2, single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162B2 (Received first COVID-19 vaccine on 06Feb2021 in the right arm, Lot# looks like an "L" EL3248), administration date: 06Feb2021, for COVID-19 immunisation, reaction(s): "No adverse effect". The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 28Feb2021, outcome "not recovered", described as "sore throat". Therapeutic measures were taken as a result of oropharyngeal pain.  Additional Information: The patient had other medical conditions but they have been going on for a long time and she did not think they were relevant. The patient did not receive other vaccines on same date with the Pfizer vaccine considered as suspect. The patient did not undergo any relevant tests. The event did not result to emergency room or physician's office visit. The patient received: Chloraseptic spray, 2 sprays every couple of hours, helps a little but, not much. Lot/expiry not seen on the bottle.  She then took Acetaminophen extra strength for adults 500 mg, 2 or 3 at a time which helped more Expiration Sep2020, ALV2304 was located right above the expiration date, there was a number below that, A8085 2E F4).  No follow-up attempts are possible. No further information is expected.
NIGHT SWEATS; BODY ACHES; CHILLS IN THE NIGHT TIME; FATIGUE; MUSCLES ACHES; This spontaneous report received from a patient concerned an 87 year old male. The patient's weight was 230 pounds, and height was 180.34 centimeters. The patient's concurrent conditions included non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies and no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 207A21A expiry: UNKNOWN) dose was not reported, administered on 05-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On JUL-2021, the subject experienced night sweats. On JUL-2021, the subject experienced body aches. On JUL-2021, the subject experienced chills in the night time. On JUL-2021, the subject experienced fatigue. On JUL-2021, the subject experienced muscles aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue, night sweats, chills in the night time, muscles aches and body aches was not reported. This report was non-serious. This case, from the same reporter is linked to 20210760407.; Sender's Comments: V0. medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Approximately 5-10 minutes after vaccination, patient was standing and fainted. He hit his chin on a counter and started having a seizure that involved tense muscles, eyes rolled back, tongue back, and patient was unconscious (unknown if the seizure started before or after hitting his chin). The seizure lasted less than 30 seconds and patient regained consciousness without treatment. The ambulance arrived shortly after and patient was taken to the hospital by father for follow-up. Patient had received influenza vaccine last year and in years past according to father and patient. Patient had never experienced a seizure in the past. Patient reported no allergies and was feeling healthy prior to vaccination.
SOME PAIN SPORADICALLY IN CHEST; PAIN IN EYE SOCKETS AN LOWER EXTREMITIES; CHILLS; PAIN IN LOWER EXTREMITIES; TIGHTNESS IN ARMS; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 22-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAY-2021, the subject experienced some pain sporadically in chest. On MAY-2021, the subject experienced pain in eye sockets an lower extremities. On MAY-2021, the subject experienced chills. On MAY-2021, the subject experienced pain in lower extremities. On MAY-2021, the subject experienced tightness in arms. On MAY-2021, the subject experienced fever. Treatment medications (dates unspecified) included: Tylenol(paracetamol). The action taken with covid-19 vaccine  was not applicable. The patient recovered from some pain sporadically in chest, pain in eye sockets an lower extremities, chills, pain in lower extremities, tightness in arms, and fever on MAY-2021. This report was non-serious.
PATIENT STARTED TO FEEL VERY TIRED AND ON SUNDAY EVENING STARTED TO GET HIVES
Cellulitis of right thigh. 1.5 cm in diameter of erythema on the top of the right thigh and 3 cm in diameter of induration. Cefdinir was prescribed for treatment.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 11-DEC-2018, the patient was vaccinated with improperly stored M-M-R II (lot # N024698, expiration date 08-SEP-2019) and hepatitis VAQTA (lot # R013859, expiration date 14-JUN-2019) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). The sterile diluent used to reconstitute M-M-R I) was properly stored. No adverse effect was reported. The vaccines were exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
Low grade fever, fussy sleep 6FEB92 t104 gas, stomach pains, vomiting; recovered 7FEB92;
Sore Throat; Cough; Weakness; body aches; Fever; This spontaneous case was reported by a nurse and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough), ASTHENIA (Weakness), MYALGIA (body aches) and PYREXIA (Fever) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough), ASTHENIA (Weakness), MYALGIA (body aches) and PYREXIA (Fever). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough), ASTHENIA (Weakness), MYALGIA (body aches) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment related information has been reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
recv vax 7/8/98 - later devel red, itchy hard area at injection site
Received vaccine on 2/9. 2/19 evening temperature 98.9. 4" red, warm, hard swelling with tenderness
NUMBNESS IN HANDS, FINGERES AND FEET. CRAMPING IN HANDS AND, FOREARMS, FEET AND CALVES
I had your vaccine and I was wondering if it was designed to help the liver? I felt that along with what I would say kinda felt like C-Type ketamine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "I had your vaccine and I was wondering if it was designed to help the liver? I felt that along with what I would say kinda felt like C-Type ketamine".  Additional information: The patient had vaccine and was wondering if it was designed to help the liver? The patient felt that along with what patient would say kinda felt like C-Type ketamine. The patient don't think it necessarily prevents infection but highly decreases the amount of deaths from the illness. The patient think COVID is kind a overrated, but the patient thought it was a good vaccine. The patient though it was genetic engineering and safe too.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
-Pain described as "hot oil" during plunger depression -Red lines coming from injection site -Patient cried out in pain -Reaction for Shingrix ONLY, Not flu -Shingrix given 0.3ML L delt, IM
Inadvertant secondary auto inoculation approx 2 inches distal from original inoculation site noted approx 4 to 5 days after vaccination.  Normal healing at both sites.
Pounding headache Fever for 2 days Ibuprofen & Nsaid medication to treat my fever On January 31st, I experienced an excessive nose bleed that afternoon, which worsened in the evening I went to the ER that evening, where they cauterized it
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Nov2021 as dose 3 (booster), single (Lot number: ER8729) at the age of 34 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid from 11Sep2022 to 16Sep2022. Clinical course: The patient had no known allergies.
Severe pain in left arm 10 hours after injection. Rash and hives 17 hours after injection. 75% better 24 hours after injection.
Patient received vaccination and spouse picked up and informed that patient was in the wrong location and had already received vaccination.
Pt developed lightheadedness, and tingling in tongue and throat. No objective swelling on exam and breath sounds were WNL. BP 140/88, HR 72, SP02 99%. Symptoms improved without intervention. The pt was offered EMS services and ER evaluation but she declined.
2ND PRIFZER LOT FD7218 GIVEN ON 12/28/21 LEFT ARM. PATIENT STATED THAT AFTER THE 1ST PFIZER SHE EXPERIENCED PHARINGITIS AND LOOSING HER VOICE AND FOLLOWED UP WITH THE DOCTOR. ON 12/28/21 AFTER VERIFYING WITH HER DOCTOR SHE DECIDED TO GET A SECOND PFIZER. SHE JUST REPORTED THAT PT HAD BREAST IMPLANT AND HER RIGHT BREAST HAS BEEN HARDEN AND HAS NOT BEEN IMPROVED EVER SINCE.
right after he got the Covid vaccine he went to the ER and his heart was working at 25% capacity. Now his heart is only down to 10%. He's going to die from this thing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. A 59-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The reporter is very upset because her brother (patient) aged 59 have had severe issues after getting the Pfizer BioNTech Covid 19 vaccine. Her brother was healthy as a horse, climbing ladder every day, never sick and heart trouble doesn't run in the family. Her brother received Pfizer BioNTech Covid 19 vaccine, immediately got sick after getting it . She initially thought his heart was messed up from a heart break, which sounds crazy but it was true.  Maybe it was because his girlfriend is dying of kidney failure.  She then found out right after he got the Covid vaccine he went to the emergency room and his heart was working at 25% capacity. Now his heart is only down to 10%. He's going to die from this thing. When he told her she started crying, he gave her his vaccination card and said she should have it in case she has to sue us after he dies.  She told him that Pfizer isn't liable for anything and they could be injecting dirt into people and there would be no repercussions. Outcome of the event was not recovered.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Developed rash 20 days post SPV. Resolved without complications and patient went to work. ACAM 2000 Baxter Healthcare Lot# VV04-003A on 12/02/2013.
Patient remained on site for 25 minutes and insisted on going home to take Benadryl, similar to what she does when she experiences these symptoms when she eats food that has shellfish or has touched shellfish. She has an EpiPen at home and I followed up to make sure she made it home okay since she did not want to remain on site. I called ~11:30 and she had made it home and just taken Benadryl. I advised to seek EMS if she has trouble breathing or continued to worsen. I called again that evening at around 6:30pm to follow up but had to leave a voicemail.
This case was reported by a consumer (subject) and described the occurrence of rapid heart rate in a 37-year-old female subject who was vaccinated with FLUARIX (manufacturer unspecified). A physician or other health care professional has not verified this report. Concurrent medical conditions included reflux (nos). Concurrent medications included NEXIUM. On 8 October 2013 at 08:45 the subject received 1st dose of influenza vaccine unspecified (unknown details). On 8 October 2013, "within 5 minutes" after vaccination with influenza vaccine unspecified, the subject experienced rapid heart rate, heart palpitation, and dizziness. On 8 October 2013, 6 hours after vaccination with influenza vaccine unspecified, the subject experienced photophobia. At the time of reporting the event of heart palpitations was unresolved. At the time of reporting, the events of rapid heart rate, dizziness and photophobia had resolved.
Sunburn feeling on backs of hands, forearms, forehead, lips, tongue, top of feet, belly and calves.  No rash or redness present.  Ongoing and unresolved after seven days.
Palms of hands turned red and blotchy after 10 -15 minutes. Pharmacist gave patient benadryl. Symptoms abated after aprox 30 minutes
Patient woke up this morning with fever up to 101, headache, felt wobbly for one hour and had a 6X6 cm area of redness with a 2cm area of vesicle cluster in the center of the redness.
Patient called on 10/21/2018 reporting that her left arm was swollen, red, warm, and tender. She complained that she has "felt bad" for 2 days now, and that her arm was so tender it hurt for her to wear shirts with sleeves. I encouraged her to seek medical attention from an urgent care facility nearby as I suspected cellulitis. At this time, the outcome is unknown/ not yet resolved.